Priyanshi Pachauri: Looking Beyond Symptomatic Treatment in Iron Deficiency Anemia
Priyanshi Pachauri, Clinical Hematologist at Fortis Healthcare, shared a post on LinkedIn:
“Iron Deficiency Anemia: Always ask why??
A 33-year-old female presented with anemia.
On evaluation:
- Peripheral smear – microcytic hypochromic picture
- Iron studies – consistent with iron deficiency anemia (IDA)
At first glance, it seemed straightforward. She was started on iron supplementation and showed hematological improvement.
But the real question was — Why did this happen? What was the underlying cause?
In women, iron deficiency anemia is often quickly attributed to menstrual blood loss or inadequate dietary intake.
While these are common causes, as hematologists, we must go a step further — especially when the patient has already received prior treatment for IDA.
This patient had a history of previous iron deficiency that had been treated. That raised concern.
A detailed and mandatory etiological workup was initiated.
The turning point?
Elevated IgA anti-tTG antibodies, which is highly suggestive of Celiac disease — a frequently overlooked but important cause of iron deficiency anemia due to malabsorption.
This case beautifully highlights:
- The importance of looking beyond symptomatic treatment
- The need to identify the root cause of iron deficiency
- The interdisciplinary role of gastroenterology in managing such patients
Iron deficiency anemia is common.
But the cause is not always obvious.
Another reminder that in hematology, every ‘simple’ case deserves thoughtful evaluation.”
Stay updated with Hemostasis Today.
-
Nov 4, 2026, 18:57Connecting Haemophilia Centres, Certifying Treaters, and Improving National Data in Romania – EHC
-
Nov 4, 2026, 18:45Smitirupa Mishra: A Practical Guide to Coagulation Pathway Assessment and Laboratory Interpretation
-
Nov 4, 2026, 15:59Alessandra Bosch: A Successful Patient Day for the Bleeding Disorders Community in Zürich
-
Nov 4, 2026, 15:47Wolfgang Miesbach: Targeting Hepatic Endothelial Cells for Lentiviral Gene Therapy in Haemophilia A
-
Nov 4, 2026, 15:20Augustina Isioma Ikusemoro: Before You Transfuse, Think PBM
-
Nov 4, 2026, 14:23Advancing Hemophilia Care Through Global Research – WFH
-
Nov 4, 2026, 14:12Jean-Jacques Kiladjian: From JAK Inhibitor-Associated Skin Cancers to Laboratory Discovery
-
Nov 4, 2026, 13:59Rita Li: ASH 2026 Abstract Achievement Award for Gut Microbiome Research
-
Nov 4, 2026, 13:38Omid Seidizadeh: Improving Access to von Willebrand Disease Diagnosis and Treatment Across Europe